Close Menu


The essential diagnostics list — which may be available by early 2019 — has the potential to play an important role in guiding healthcare policies.


The Global Health Technologies Coalition said that an essential diagnostics list would spur innovation and make the correct diagnostic tests available where they are needed the most. 

The kit is a qualitative nucleic acid assay designed to test for Zika, dengue, and chikungunya viruses simultaneously.

The RealStar Zika Virus RT-PCR Kit 1.0 has been listed by the World Health Organization as eligible for procurement agencies and member states.

Prequalification now enables procurement in numerous countries within sub-Saharan Africa that have regulations requiring this type of oversight.